UNH's dip to $250 offers a strong buy opportunity with solid revenue growth, resilient dividends, and historic low P/E.

UnitedHealth has gone from bad to worse, and its drop is impacting the Dow Jones Industrial Average even more than it is the ...

Rising Treasury yields, Moody’s downgrade, and U.S. budget worries weigh on S&P 500 and tech stocks, pressuring US indices ...

The probe has reportedly been active since at least summer 2024. The DOJ is yet to comment publicly on the matter. This alleged criminal investigation adds to a growing list of government inquiries ...

The double downgrade comes a day after the stock tumbled 17.8% on Tuesday to close at a near five-year low. While the stock edged up 0.7% in midday trading on Wednesday, it has plunged 46.4% since ...

The Motley Fool reaches millions of people every month through our premium investing solutions, free guidance and market analysis on Fool.com, top-rated podcasts, and non-profit The Motley Fool ...

UnitedHealth Group Incorporated operates as a health care company in the United States and internationally. The company operates through four segments: UnitedHealthcare, Optum Health, Optum ...

Dow Jones outperforms with help from health stocks; S&P500 and Nasdaq rally while Nvidia earnings loom next week.

What Happened? Shares of health insurance company UnitedHealth (NYSE:UNH) fell 16% in the morning session after the Wall Street Journal reported that the Justice Department was investigating the ...

UnitedHealth stock is rising after declining for eight consecutive sessions ... To watch more expert insights and analysis on the latest market action, check out more Market Domination here.

A new report claims UnitedHealthcare is actively working to limit access to applied behavior analysis therapy, a critical treatment for patients with autism. UnitedHealth Group CEO Andrew Witty ...